MRNA

Moderna, Inc.

Health Care · Biotechnology

$53.19 sample

+0.55 (+1.04%) 1D

Market cap

$258.0B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-03

Alerts

8

Price$53.19 +3.56% 3M daily closessample

54.8749.68

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 09INSInsider sell: EVP, Operations
Oct 01INSInsider sell: General Counsel
Sep 22INSInsider buy: EVP, Operations
Sep 15INSInsider sell: Chief Executive Officer
Sep 09INSInsider sell: Chief Executive Officer
Sep 03SECDEF 14A filed
Aug 31INSInsider sell: Chief Executive Officer
Aug 21INSInsider buy: Chief Executive Officer

Sign up to see the real MRNA record →

Company facts

SEC EDGAR registration

Name: Moderna, Inc.
Sector: Health Care
Industry: Biotechnology
Smart-money score: -16sample, -100 to +100
Reporting currency: USD

Who is positioning in MRNA

sample

Insiders: 22 insider transactions over 90 days, net selling, $31.1M
Congress: 1 members traded over 90 days
Institutions · 13F: 15 funds hold $2.1B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$11.7B +15.6% y/y

Q4 2024Q3 2026

Inventory$7.0B +4.4% y/y

Q4 2024Q3 2026

Accounts receivable$5.2B +8.2% y/y

Q4 2024Q3 2026

Total debt$14.5B +8.6% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $87.9B +6.3% 3M
Sample peer B: $240.4B +14.6% 3M
Sample peer C: $63.8B +1.9% 3M
Sample peer D: $86.4B +7.0% 3M
Sample peer E: $60.0B -0.5% 3M